This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Marc-André Frese
Introduction
Marc-André Frese is a notable inventor based in Enger, Germany. He has made significant contributions to the field of molecular biology, particularly in understanding ribosomal translational events. His work has implications for both therapeutic and clinical applications, especially in diseases related to protein accumulation.
Latest Patents
Frese holds a patent titled "Molecular constructs and uses thereof in ribosomal translational events." This patent focuses on stalled ribosome:nascent molecule of interest complexes and methods for their use. It also discloses plasmids, particularly DNA plasmids, that comprise a stall segment. The methods outlined in the patent facilitate the stable formation of these complexes, which can be utilized to examine protein synthesis and conformational events. Additionally, the patent discusses the creation of desired ribosomal displays and includes cells transformed with these plasmids, covering both eukaryotic and prokaryotic cells.
Career Highlights
Throughout his career, Frese has demonstrated a commitment to advancing scientific knowledge in molecular biology. His innovative approaches have led to the development of methods that can be applied in various therapeutic contexts. His patent reflects a deep understanding of the complexities involved in protein synthesis and the potential for addressing defects in protein accumulation.
Collaborations
Frese has collaborated with notable colleagues, including Patricia L Clark and Michael Scott Evans. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his work in the scientific community.
Conclusion
Marc-André Frese's contributions to molecular biology through his innovative patent highlight the importance of research in understanding ribosomal functions. His work not only advances scientific knowledge but also opens avenues for therapeutic applications in addressing protein-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile